Deisenhammer F., Egg R., Giovannoni G., et al. EFNS guidelines on disease-specific CSF investigations. Eur J Neurol2009; 16: 760-770.
2.
Deisenhammer F., Bartos A., Egg R., et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol2006; 13: 913-922.
3.
Bielekova B. , Martin R.Development of biomarkers in multiple sclerosis . Brain2004; 127: 1463-1478.
4.
Teunissen CE , Dijkstra CD, Polman CHBiological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol2005; 4: 32-41.
5.
Teunissen CE , Petzold A., Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking, Neurology2009;731914-1922.
6.
Plebani M.Errors in clinical laboratories or errors in laboratory medicine?Clin Chem Lab Med2006; 44: 750-759.
7.
Jimenez CR, Koel-Simmelink MJR, Pham T., Voort van der L., Teunissen CEEndogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry . Proteomics Clin Appl2007; 1: 1385-1392.